SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001019687-11-002893
Filing Date
2011-09-02
Accepted
2011-09-02 16:14:48
Documents
6
Period of Report
2011-09-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K peregrine_8k-090211.htm 8-K 45508
2 PLACEMENT AGENCY AGREEMENT peregrine_8k-ex0101.htm EX-1.1 270158
3 OPINION peregrine_8k-ex0501.htm EX-5.1 11740
4 SUBSCRIPTION AGREEMENT peregrine_8k-ex1030.htm EX-10.30 81753
5 PRESS RELEASE peregrine_8k-ex9901.htm EX-99.1 9324
6 peregrine_8k-ex99010.jpg GRAPHIC 4806
  Complete submission text file 0001019687-11-002893.txt   426533
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-32839 | Film No.: 111073822
SIC: 2834 Pharmaceutical Preparations